Open AccessLY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancerviadeath receptor pathway
Author(s) -
Jie Liu,
Xueqiong Fu,
Wei Zhou,
Honggang Yu,
Jie-Ping Yu,
Hao Luo
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i2.181
Subject(s) - oxaliplatin , fas ligand , protein kinase b , apoptosis , chemistry , programmed cell death , cancer research , ly294002 , cancer cell , pi3k/akt/mtor pathway , cell growth , pharmacology , microbiology and biotechnology , biology , medicine , cancer , biochemistry , colorectal cancer
To examine the effects of combined treatment of oxaliplatin and phosphatidylinositol 3'-kinase inhibitor, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) for gastric cancer.